Important notice

Labour dispute at Canada Post

We have put in place measures to mitigate the impact on our clients.

Gouvernement du Québec
Régie de l’assurance maladie

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

4762 results found.

Example of search result explained

Relaxa

Exceptional medication
  • Active ingredient(s):
    polyethylene glycol
  • Manufactured by:
    Medexus Inc. (Medexus)
  • Strength and dosage form:
    Oral Powder 1 g/g DIN : 2346672

Relaxa (30 packs of 17 grams)

Exceptional medication
  • Active ingredient(s):
    polyethylene glycol
  • Manufactured by:
    Medexus Inc. (Medexus)
  • Strength and dosage form:
    Oral Powder 1 g/g DIN : 99101166

Jamplyte (280g)

Exceptional medication

PegLyte (280 g)

Exceptional medication

Bioderm

Covered

Jampolycin

Covered

Jamp Calcium Polystyrene Sulfonate

Covered
  • Active ingredient(s):
    calcium polystyrene sulphonate
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    Oral Powder Exchange capacity: 1.6 mmol of k/g DIN : 2502631

Resonium Calcium

Covered
  • Active ingredient(s):
    calcium polystyrene sulphonate
  • Manufactured by:
    Sanofi-Aventis Canada Inc. (SanofiAven)
  • Strength and dosage form:
    Oral Powder Exchange capacity: 1.6 mmol of k/g DIN : 2017741

Jamp Sodium Polystyrene Sulfonate

Covered
  • Active ingredient(s):
    polystyrene sodium sulfonate
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    Oral Powder Exchange capacity: 1 mmol of k/g DIN : 2497557

Kayexalate

Covered
  • Active ingredient(s):
    polystyrene sodium sulfonate
  • Manufactured by:
    Sanofi-Aventis Canada Inc. (SanofiAven)
  • Strength and dosage form:
    Oral Powder Exchange capacity: 1 mmol of k/g DIN : 2026961
Page 348 of 477

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.